Skip to content

SCREENER CHART SD50 CALENDAR NEWS

...

Bright Minds Biosciences Inc. (DRUG) Stock · SELL · CRISIS | LOPJLB

Bright Minds Biosciences Inc. (DRUG)

Healthcare · Biotechnology · NASDAQ · US

$52.00+0.00%Close

SELLCRISIS · day 28

DRUG▼ SELL

$52.00+0.00%

Overview FinancialsFin EarningsEarn Analyst & RatingsAnalyst News Holders & ETFsHold Options

Key stats

Short interest · FINRA settlement 2026-09-15

Market cap: $509M
Beta: 0.09
P/E (TTM): -23.86

Short % float: 15.26%
Days to cover: 12.0
SI change: +4.3%

1W: +5.67%
1M: -20.07%

vs SPY 1W: +4.11%
vs SPY 1M: -21.84%

Industry peers

FMP comparable companies · ranked by market cap

LBRXSELLLB Pharmaceuticals Inc Common Stock$1.1BCRISISQ 76$36.99+1.32%
DSGNSELLDesign Therapeutics, Inc.$771MCRISISQ -13$12.34-1.71%
ANNXSELLAnnexon, Inc.$687MRECOVERYQ -8$4.19-0.25%
AURASELLAura Biosciences, Inc.$630MRECOVERYQ -6$6.09+0.77%
IMABI-Mab$542M$2.88
ALTSELLAltimmune, Inc.$532MCRISISQ -5$2.73-2.26%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric…

Employees: 26
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 9.8M
Float: 62.4%

brightmindsbio.com ↗

Key executives

Ian McDonald — Co-Founder, Chief Executive Officer, President & Director

Jan Torleif Pedersen — Chief Science Officer & Director

Stephen D. Collins — Chief Medical Officer

SEC filings

EDGAR · CIK 18274010 · DRUG

All filings
10-K
10-Q
8-K
Form 4

Analyst consensus

Buy

Bullish4100.0%

Neutral00.0%

Bearish00.0%

L $145.00Avg $182.50H $220.00

Target$182.50+250.96%

Last$52.00

Company news

globenewswire.com · 9d ago

Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference

globenewswire.com · 35d ago

Bright Minds Biosciences to Present at Upcoming Conferences

zacks.com · 43d ago

What Makes Bright Minds Biosciences Inc. (DRUG) a Strong Momentum Stock: Buy Now?

zacks.com · 44d ago

Wall Street Analysts See a 97.01% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?

zacks.com · 60d ago

Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 97.4%: Read This Before Placing a Bet

globenewswire.com · 70d ago

Vistagen Appoints Douglas J. Williamson to its Board of Directors

zacks.com · 78d ago

Wall Street Analysts See a 107.53% Upside in Bright Minds Biosciences Inc. (DRUG): Can the Stock Really Move This High?

zacks.com · 79d ago

All You Need to Know About Bright Minds Biosciences Inc. (DRUG) Rating Upgrade to Strong Buy

Market news & ticker search · RSS for DRUG

LOPJLB

Independent quant research on U.S. equities & ETFs. Not personalized advice.

Product

Screener Chart Compare SD50 Thesis News Calendar

Desk

Market Heatmap Market Hours FOMC Desk Treasury Rates Congress Trades Prediction Markets

Research

How It Works Methodology Track Record Editorial Blog Changelog

Ledgers

Bull Spreads Cash-Secured Puts Covered Calls Long Puts Long Calls

Screeners

CEF Screener REIT Screener BDC Screener Preferred Screener Dividend Screener ETF Screener Crypto Screener S&P 500 Screener

Company

Pricing About Contact

Agents

GitHub·Research Chat·MCPENT·Developers

© 2026 LOPJLB Research. All rights reserved.

@lopjlb contact@lopjlb.com

RANGE

LOPJLB.COM

OHLC🔒EMALEVELS🔒STOP🔒FLIP🔒52WSIGNALS🔒BUY🔒SELL🔒EXH🔒EXH ZONE